Q4 FY2018 · Proxy statement
Read Halozyme Therapeutics, Inc.'s results firsthand
Preview the first 2 pages of this proxy statement
Create a free account to start reading
Full documents are included with Professional
Halozyme Therapeutics, Inc.
130.34
USD
+1.72
(+1.34%)
